Arquiza, Placido .
HRN: 21-47-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
MUPIROCIN 2%, 15G (TUBE)
06/27/2022
07/03/2022
TOPICAL
1 Dab
BID
Abrassions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes